Letter regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study".

Circulation

Volumn 112, Issue 17, 2005, Pages

  Tricoci, Pierluigi ^a   Harrington, Robert A ^a   Valgimigli, Marco ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; TICLOPIDINE;

CORONARY ARTERY BYPASS GRAFT; HEART INFARCTION; HUMAN; NOTE; TRANSLUMINAL CORONARY ANGIOPLASTY; PREOPERATIVE CARE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; PREOPERATIVE CARE;

EID: 33644873622     PISSN: None     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.568139     Document Type: Note

References (0)